REQUEST A DEMO
Total
USD $0.00
Search more companies

Stenocoat Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Engineering Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services
Full name: Stenocoat Sp. z o.o. Profile Updated: April 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Stenocoat Sp. z o.o. is a company in Poland, with a head office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on January 23, 2020. A negative growth of 17.85% was recorded in its total assets.

Headquarters
Ul. Symboliczna 3/92
Warsaw; Mazowieckie; Postal Code: 01-252

Contact Details: Purchase the Stenocoat Sp. z o.o. report to view the information.

Website: http://www.stenocoat.com

Basic Information
Registered Capital:
Purchase the Stenocoat Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Stenocoat Sp. z o.o. report to view the information.
Incorporation Date:
January 23, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Stenocoat Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit
16.51%
EBITDA
16.51%
Net Profit/Loss for the Period
16.51%
Total Assets
-17.85%
Total Equity
-18.04%
Return on Equity (ROE)
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?